title: 0.2% ropivacaine epidurally provides better analgesia and recovery than general anesthesia for patients undergoing oncological mastectomy.
authors.affiliation: Brookdale University Hospital and Medical Center, 1 Brookdale Plaza, New York, NY 11212, USA.
authors.forename: N W
authors.initials: NW
authors.lastname: Doss
authors.forename: J
authors.initials: J
authors.lastname: Ipe
authors.forename: T
authors.initials: T
authors.lastname: Crimi
authors.forename: S
authors.initials: S
authors.lastname: Rajpal
authors.forename: S
authors.initials: S
authors.lastname: Cohen
authors.forename: R J
authors.initials: RJ
authors.lastname: Fogler
authors.forename: R
authors.initials: R
authors.lastname: Michael
authors.forename: J
authors.initials: J
authors.lastname: Gintautas
mesh_terms: D000328:Adult; D000577:Amides; D000762:Anesthesia Recovery Period; D000767:Anesthesia, Epidural; D000768:Anesthesia, General; D000779:Anesthetics, Local; D001794:Blood Pressure / Q000187:drug effects; D001943:Breast Neoplasms / Q000601:surgery*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008408:Mastectomy; D010149:Postoperative Pain / Q000188:drug therapy / Q000453:epidemiology; D011446:Prospective Studies; D000077212:Ropivacaine
chemical_list: D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine